Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novozymes A/S    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novozymes A/S
Novozymes AS is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market are as follows:

- domestic cleaning and servicing products industry (33.1%);

- food industry (29%);

- bioenergy (19.6%);

- agriculture and animal feed industry (13.1%): enzymes used to improve the productivity and digestion of foods;

- wastewater treatment and technical industry (5.2%): micro-organisms used in the wastewater treatment, technical enzymes for the textile, leather, pulp and paper industries.

At the end of 2019, the group operated 16 production sites around the world.

Net sales are distributed geographically as follows: Denmark (1.2%), Europe/Middle East/Africa (35.8%), North America (33%), Asia/Pacific (20%) and Latin America (9.8%).

Number of employees : 6 125 people.
Sales per Business
20182019Delta
DKK (in Million)%DKK (in Million)%
Household Care4,62532.1%4,75833.1% +2.88%
Food & Beverages4,12228.6%4,17129% +1.19%
Bionergy2,80619.5%2,82019.6% +0.5%
Agriculture & Feed2,04514.2%1,88113.1% -8.02%
Technical & Pharma792.005.5%744.005.2% -6.06%
Sales per region
20182019Delta
DKK (in Million)%DKK (in Million)%
Rest of Europe, Middle East & Africa5,01034.8%5,17436% +3.27%
North America4,89334%4,75033% -2.92%
Asia Pacific2,90220.2%2,87720% -0.86%
Latin America1,3819.6%1,4079.8% +1.88%
Denmark204.001.4%166.001.2% -18.63%
Managers and Directors
NameAgeSinceTitle
Ester Baiget-2020President & Chief Executive Officer
Jørgen Buhl Rasmussen652017Chairman
Graziela Chaluppe dos Santos Malucelli-2020Chief Operating Officer & Executive VP
Lars Green532019Chief Financial Officer & Executive Vice President
Claus Crone Fuglsang522020Chief Scientific Officer & Executive VP
Carl Erik Mathias Uhlén, Dr.662007Independent Director
Lars Bo Køppler582010Director
Lena Bech Holskov532013Director
Anders Hentze Knudsen612013Director
Kasim Kutay552017Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 231,256,400 204,912,325 88.6% 5,877,779 2.5% 71.9%
Stock B 20 53,743,600 0 0.0% 0 0.0%
Shareholders
NameEquities%
Novo Nordisk Fonden 20,404,050 8.82%
Norges Bank Investment Management 14,170,815 6.13%
Baillie Gifford & Co. 6,639,709 2.87%
MFS International (UK) Ltd. 6,422,263 2.78%
Novozymes A/S 6,156,216 2.66%
The Vanguard Group, Inc. 5,442,896 2.35%
Canada Pension Plan Investment Board 3,387,000 1.46%
Amundi Asset Management SA (Investment Management) 3,288,996 1.42%
Harding Loevner LP 2,852,914 1.23%
Walter Scott & Partners Ltd. 2,794,578 1.21%
Holdings
NameEquities%Valuation
Novozymes A/S (NZYM B) 6,156,2162.66%355,774,125 USD
Markets and indexes
-
- Main Market Large
- OMXC 20 / Low Carbon 100 Europe, NASDAQ OMX Nordic 120, OMX Nordic 40, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  NZYMB:DC
- Reuters Code :  NZYMb.CO
- Datastream Code :  
Company contact information
Novozymes A/S
Krogshojvej 36
DK-2880 Bagsvaerd


Phone : +45 44 46 00 00
Fax : +45 44 46 99 99
web site : http://www.novozymes.com
Sector Specialty Chemicals